1428 related articles for article (PubMed ID: 22217193)
1. Pharmacologic prevention of microvascular and macrovascular complications in diabetes mellitus: implications of the results of recent clinical trials in type 2 diabetes.
Tandon N; Ali MK; Narayan KM
Am J Cardiovasc Drugs; 2012 Feb; 12(1):7-22. PubMed ID: 22217193
[TBL] [Abstract][Full Text] [Related]
2. Intensive glucose therapy and clinical implications of recent data: a consensus statement from the Global Task Force on Glycaemic Control.
Akalin S; Berntorp K; Ceriello A; Das AK; Kilpatrick ES; Koblik T; Munichoodappa CS; Pan CY; Rosenthall W; Shestakova M; Wolnik B; Woo V; Yang WY; Yilmaz MT;
Int J Clin Pract; 2009 Oct; 63(10):1421-5. PubMed ID: 19769698
[TBL] [Abstract][Full Text] [Related]
3. Early and intensive therapy for management of hyperglycemia and cardiovascular risk factors in patients with type 2 diabetes.
Dailey G
Clin Ther; 2011 Jun; 33(6):665-78. PubMed ID: 21704233
[TBL] [Abstract][Full Text] [Related]
4. Impact of glycemic treatment choices on cardiovascular complications in type 2 diabetes.
Weiss IA; Valiquette G; Schwarcz MD
Cardiol Rev; 2009; 17(4):165-75. PubMed ID: 19525678
[TBL] [Abstract][Full Text] [Related]
5. Blood pressure targets in subjects with type 2 diabetes mellitus/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials.
Bangalore S; Kumar S; Lobach I; Messerli FH
Circulation; 2011 Jun; 123(24):2799-810, 9 p following 810. PubMed ID: 21632497
[TBL] [Abstract][Full Text] [Related]
6. Benefits of lipid-lowering therapy in patients with type 2 diabetes mellitus.
Betteridge J
Am J Med; 2005 Dec; 118 Suppl 12A():10-5. PubMed ID: 16356802
[TBL] [Abstract][Full Text] [Related]
7. Glycemic targets for patients with type 2 diabetes mellitus.
Hamnvik OP; McMahon GT
Mt Sinai J Med; 2009 Jun; 76(3):227-33. PubMed ID: 19421966
[TBL] [Abstract][Full Text] [Related]
8. Advances in reducing the burden of vascular disease in type 2 diabetes.
Chalmers J; Joshi R; Patel A
Clin Exp Pharmacol Physiol; 2008 Apr; 35(4):434-7. PubMed ID: 18307736
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of recent lipid trials on reducing risk in patients with type 2 diabetes mellitus.
Jones PH
Am J Cardiol; 2007 Feb; 99(4A):133B-140B. PubMed ID: 17307065
[TBL] [Abstract][Full Text] [Related]
10. Intensive statin therapy for Indians: Part-I. Benefits.
Enas EA; Pazhoor HC; Kuruvila A; Vijayaraghavan K
Indian Heart J; 2011; 63(3):211-27. PubMed ID: 22734339
[TBL] [Abstract][Full Text] [Related]
11. Trials of cardiovascular risk factor management in type 2 diabetes.
Patel A; Joshi R; de Galan B
Curr Opin Cardiol; 2009 Jul; 24(4):288-94. PubMed ID: 19322080
[TBL] [Abstract][Full Text] [Related]
12. Lipid-lowering therapy in patients with type 2 diabetes: the case for early intervention.
Steinmetz A
Diabetes Metab Res Rev; 2008; 24(4):286-93. PubMed ID: 18273835
[TBL] [Abstract][Full Text] [Related]
13. Effect of intensive glycemic control on cardiovascular outcomes and all-cause mortality in type 2 diabetes: Overview and metaanalysis of five trials.
Tkác I
Diabetes Res Clin Pract; 2009 Dec; 86 Suppl 1():S57-62. PubMed ID: 20115934
[TBL] [Abstract][Full Text] [Related]
14. ADVANCE: action in diabetes and vascular disease.
Patel A; Chalmers J; Poulter N
J Hum Hypertens; 2005 Jun; 19 Suppl 1():S27-32. PubMed ID: 16075030
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic potential of aleglitazar, a new dual PPAR-α/γ agonist: implications for cardiovascular disease in patients with diabetes mellitus.
Cavender MA; Lincoff AM
Am J Cardiovasc Drugs; 2010; 10(4):209-16. PubMed ID: 20653327
[TBL] [Abstract][Full Text] [Related]
16. New treatment guidelines for a patient with diabetes and hypertension.
Mogensen CE
J Hypertens Suppl; 2003 Mar; 21(1):S25-30. PubMed ID: 12769164
[TBL] [Abstract][Full Text] [Related]
17. Implications of new diabetes treatment trials: should current clinical practice be altered?
Kravetz JD; Federman DG
Postgrad Med; 2009 May; 121(3):67-72. PubMed ID: 19491542
[TBL] [Abstract][Full Text] [Related]
18. Hyperlipidaemia and cardiovascular disease: do fibrates have a role?
Saha SA; Arora RR
Curr Opin Lipidol; 2011 Aug; 22(4):270-6. PubMed ID: 21519250
[TBL] [Abstract][Full Text] [Related]
19. Statins and diabetes.
Carmena R; Betteridge DJ
Semin Vasc Med; 2004 Nov; 4(4):321-32. PubMed ID: 15861314
[TBL] [Abstract][Full Text] [Related]
20. CARDS on the table: should everybody with type 2 diabetes take a statin?
Lee JD; Morrissey JR; Mikhailidis DP; Patel V
Curr Med Res Opin; 2005 Mar; 21(3):357-62. PubMed ID: 15811203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]